Status: Not yet recruiting
Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia
The purpose of this study is to determine whether Wharton's Jelly mesenchymal stem cell-derived exosome microneedling on the scalp is an effective treatment for Androgenetic Alopecia (pattern hair loss).
Participants needed: 100
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Levit DermatologyUpdated: Jul 16, 2024Locations: 1
Eligibility criteria
Participant is experiencing hair loss and is diagnosed with Androgenetic Alopeci...
Patients cannot have taken any medications, therapies, or treatment modalities o... [+4]